What is FendX Technologies?
FendX Technologies operates at the intersection of advanced materials science and public health, specializing in the development of nanotechnology-based products designed to mitigate the transmission of pathogens. By leveraging a sophisticated intellectual property portfolio, the company has established a strong defensive moat, with nonprovisional national stage patent applications secured across key international markets including Canada, the United States, Europe, China, Hong Kong, and Japan. This strategic positioning allows FendX to address critical safety concerns in high-traffic environments, effectively bridging the gap between laboratory innovation and commercial application in the global hygiene and sanitation sector.
How much funding has FendX Technologies raised?
FendX Technologies has raised a total of $511K across 3 funding rounds:
Stock/Share Issuance
$100K
Stock/Share Issuance
$357K
Stock/Share Issuance
$54K
Stock/Share Issuance (2025): $100K, investors not publicly disclosed
Stock/Share Issuance (2025): $357K, investors not publicly disclosed
Stock/Share Issuance (2026): $54K, investors not publicly disclosed
Key Investors in FendX Technologies
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for FendX Technologies?
With the recent injection of capital, FendX Technologies is well-positioned to accelerate its commercialization roadmap and deepen its penetration into international markets. The company is expected to prioritize the transition of its patent-protected technologies from development phases to large-scale manufacturing and distribution. By focusing on operational scaling and regulatory milestones in its primary jurisdictions, FendX aims to solidify its role as a leader in pathogen-reduction technology. Future strategic initiatives will likely involve expanding its R&D capabilities to address emerging biological threats, thereby enhancing the long-term value proposition for stakeholders and reinforcing its competitive advantage in the nanotechnology landscape.
See full FendX Technologies company page
